- Report
- May 2025
- 146 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- August 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- September 2025
- 402 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- February 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- January 2025
- 768 Pages
Global
From €4232EUR$4,799USD£3,664GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- November 2024
- 799 Pages
Global
From €4232EUR$4,799USD£3,664GBP
- Report
- March 2025
- 300 Pages +
Global
From €4232EUR$4,799USD£3,664GBP
- Report
- May 2025
- 483 Pages
Global
From €5201EUR$6,103USD£4,350GBP
- Report
- April 2025
- 140 Pages
Global
From €4321EUR$4,900USD£3,741GBP
- Report
- May 2025
- 140 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- August 2025
- 193 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 196 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 199 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP

The Viral Vector Manufacturing market is a subset of the genomics industry that focuses on the production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, cystic fibrosis, and hemophilia.
The Viral Vector Manufacturing market is highly competitive, with a number of companies offering a range of services. These services include vector design, vector production, and vector characterization. Companies also provide custom services to meet the specific needs of their customers.
Some of the major players in the Viral Vector Manufacturing market include Lonza, Thermo Fisher Scientific, Merck KGaA, and Oxford BioMedica. These companies offer a range of services, from vector design to vector production and characterization. Show Less Read more